Covalon Technologies Stock Today
| COV Stock | CAD 3.22 0.11 3.30% |
Performance19 of 100
| Odds Of DistressLess than 17
|
Covalon Technologies is selling for under 3.22 as of the 6th of October 2024; that is 3.3% down since the beginning of the trading day. The stock's lowest day price was 3.2. Covalon Technologies has less than a 17 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. Equity ratings for Covalon Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of July 2024 and ending today, the 6th of October 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Covalon Technologies Ltd. researches, develops, manufactures, commercializes, and licenses medical technologies and products in the United States, Canada, the United Kingdom, Europe, the Middle East, Asia, Latin America, and internationally. It serves hospitals, wound care centers, burn centers, extendedalternate care and acute care facilities, home health care agencies, and physicians offices. The company has 27.4 M outstanding shares of which 3 K shares are currently shorted by private and institutional investors with about 0.06 days to cover all short positions. More on Covalon Technologies
Moving together with Covalon Stock
| 0.7 | FFH | Fairfax Financial | PairCorr |
| 0.88 | IFC | Intact Financial | PairCorr |
| 0.73 | WSP | WSP Global | PairCorr |
| 0.75 | FSV | FirstService Corp | PairCorr |
Moving against Covalon Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Covalon Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Covalon Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Covalon Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Director | Brent Ashton | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Covalon Technologies' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Covalon Technologies' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsCovalon Technologies can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Covalon Technologies' financial leverage. It provides some insight into what part of Covalon Technologies' total assets is financed by creditors.
| |||||
Covalon Technologies (COV) is traded on TSX Venture Exchange in Canada and employs 28 people. Covalon Technologies is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 88.22 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Covalon Technologies's market, we take the total number of its shares issued and multiply it by Covalon Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Covalon Technologies classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 27.4 M outstanding shares of which 3 K shares are currently shorted by private and institutional investors with about 0.06 days to cover all short positions.
Covalon Technologies has accumulated about 2.53 M in cash with (3.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.1.
Check Covalon Technologies Probability Of Bankruptcy
Ownership AllocationCovalon Technologies holds a total of 27.4 Million outstanding shares. Covalon Technologies retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Covalon Ownership Details
Covalon Technologies Risk Profiles
Although Covalon Technologies' alpha and beta are two of the key measurements used to evaluate Covalon Technologies' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.09 | |||
| Semi Deviation | 1.57 | |||
| Standard Deviation | 2.89 | |||
| Variance | 8.34 |
Covalon Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Covalon Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Share Portfolio Now
Share PortfolioTrack or share privately all of your investments from the convenience of any device |
| All Next | Launch Module |
Covalon Technologies Corporate Directors
| John Hands | Senior Director - Global Marketing | Profile | |
| Ian Brindle | Independent Director | Profile | |
| Joseph Cordiano | Independent Director | Profile | |
| Ronald Smith | Director | Profile |
Additional Tools for Covalon Stock Analysis
When running Covalon Technologies' price analysis, check to measure Covalon Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Covalon Technologies is operating at the current time. Most of Covalon Technologies' value examination focuses on studying past and present price action to predict the probability of Covalon Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Covalon Technologies' price. Additionally, you may evaluate how the addition of Covalon Technologies to your portfolios can decrease your overall portfolio volatility.